CDK6 and central nervous system cancer: It has also beendemonstrated that exogenous administration of proapoptotic miR-218 suppressesexpression of cyclin-dependent kinase 6 (CDK6), reduces proliferation, andcauses apoptotic death of glioma cells [105].